Revier Therapeutics

Cardior

This company develops RNA-based therapeutics designed to prevent, repair and reverse heart diseases for patients with cardiac dysfunctions.

Rivus Pharmaceuticals

The company develops oral small-molecule medicines for patients with obesity and associated cardiometabolic diseases including heart failure and type 2 diabetes.

Brano Therapeutics

This company develops small-molecule inhibitors to treat heart failure and metabolic dysfunction for patients with cardiovascular diseases.

AnaCardio

This biopharmaceutical company develops oral small-molecule drugs to improve cardiac contractility in patients with heart failure.

Cardurion Pharmaceuticals

This clinical-stage biotechnology company develops therapeutic drugs for patients with heart failure and other cardiovascular diseases.

Allosteros Therapeutics, Inc

The company develops small-molecule inhibitors of the protein kinase CaMKII to treat cardiovascular conditions including atrial fibrillation, ventricular arrhythmia and heart failure.

HDAX Therapeutics

This biotechnology company develops small molecule inhibitors targeting the HDAC6 protein to treat patients with neuropathies, heart failure and various cancer conditions.

NanoPhoria

This company develops an inhalable nano-drug delivery platform and therapeutics for patients with heart failure and other cardiovascular diseases.